Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$205,195,560
+$27,825,289 QoQ
Shares Held
815,433
-0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#158
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $890,953,075 across 8 Drug Manufacturers - General names. ABBV ranks #2 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
875,123 | $222,254,988 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
815,433 | $205,195,560 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,087,644 | $139,762,254 | |
| 4 | LLY |
ELI LILLY & Co
|
114,449 | $137,273,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
530,870 | $67,070,115 | |
| 6 | PFE |
Pfizer Inc
|
2,658,388 | $64,013,983 | |
| 7 | AMGN |
Amgen Inc
|
96,618 | $34,987,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
353,962 | $20,395,290 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,195,560 | 815,433 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $177,370,271 | 815,533 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $155,906,267 | 682,333 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $182,401,191 | 787,774 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $152,171,090 | 819,799 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $170,769,904 | 815,053 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $134,494,199 | 756,861 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $168,491,318 | 853,207 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $131,866,634 | 768,812 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $131,710,380 | 723,286 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $98,760,211 | 637,286 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $101,586,476 | 681,514 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $91,597,941 | 679,863 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $107,061,897 | 671,782 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $105,391,537 | 652,135 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $83,637,390 | 623,183 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $101,154,368 | 660,449 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $101,113,518 | 623,734 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $81,144,678 | 599,296 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $59,764,186 | 554,039 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $59,840,901 | 531,258 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $56,220,398 | 519,501 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $57,344,858 | 535,183 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,165,493 | 561,314 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $57,223,329 | 582,841 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $35,413,873 | 464,810 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||